Cargando…

Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis

Neurofilament light (NFL) is a putative biomarker of neurodegeneration. This study evaluates the correlative association of NFL with Alzheimer's disease (AD) indices. Relevant studies were identified after a literature search in electronic databases and study selection was based on pre-determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Mei, Cao, Li, Dai, Yan-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753203/ https://www.ncbi.nlm.nih.gov/pubmed/31572170 http://dx.doi.org/10.3389/fnagi.2019.00254

Ejemplares similares

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Neurofilament Light Chain: A Candidate Biomarker of Perioperative Stroke
por: Zhang, Xiaoting, et al.
Publicado: (2022)

The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
por: Frempong, Bernice, et al.
Publicado: (2021)

Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
por: Loeffler, Tina, et al.
Publicado: (2020)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients
por: Ingannato, Assunta, et al.
Publicado: (2021)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease
por: Parvizi, Tandis, et al.
Publicado: (2022)

Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China
por: Jiao, Bin, et al.
Publicado: (2021)

Plasma Neurofilament Light Chain May Be a Biomarker for the Inverse Association Between Cancers and Neurodegenerative Diseases
por: Liu, Shunjie, et al.
Publicado: (2020)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
por: Thebault, Simon, et al.
Publicado: (2021)

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
por: Zanardini, Roberta, et al.
Publicado: (2022)

Plasma Neurofilament Light Chain as a Predictive Biomarker for Post-stroke Cognitive Impairment: A Prospective Cohort Study
por: Wang, Zhiqiang, et al.
Publicado: (2021)

Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions
por: Abed, Sadiruldeen Sami, et al.
Publicado: (2023)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Neurofilament Light Chain as A Biomarker for Brain Metastases
por: Winther-Larsen, Anne, et al.
Publicado: (2020)

Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie
por: Betancor, Marina, et al.
Publicado: (2022)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
por: Zhang, Piao, et al.
Publicado: (2022)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Altered amide proton transfer weighted and diffusion signals in patients with multiple sclerosis: correlation with neurofilament light chain and disease duration
por: Huang, Jing, et al.
Publicado: (2023)

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
por: Herbert, Megan K., et al.
Publicado: (2015)

Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain
por: Gaetani, Lorenzo, et al.
Publicado: (2021)

Serum Neurofilament Light Chain: A Marker of Nervous System Damage in Myopathies
por: Saak, Annika, et al.
Publicado: (2021)

Neurofilament Light Chain as a Biomarker for Monitoring the Efficacy of Transcranial Magnetic Stimulation on Alcohol Use Disorder
por: Zhang, Tian, et al.
Publicado: (2022)

Plasma neurofilament light chain as a potential biomarker of neurodegeneration in murine brain
por: Sano, Tomoya, et al.
Publicado: (2023)

Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome
por: Eisenstein, Sarah A., et al.
Publicado: (2022)

Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016)

Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
por: Depoorter, Antoinette, et al.
Publicado: (2018)

Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2021)

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
por: Donath, H., et al.
Publicado: (2021)

Neurofilament Light Chain Is a Promising Biomarker in Alcohol Dependence
por: Li, Yanfei, et al.
Publicado: (2021)

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2021)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2023)

Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
por: Canaslan, Sezgi, et al.
Publicado: (2021)

Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye
por: Bai, Jianhao, et al.
Publicado: (2022)

Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer’s disease: A biochemical analysis in Pakistani population
por: Faraz Ahmed, Tehniat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a29uleu9eqrje9nruvv3asm8a0